HSE approves reimbursement for Friedreich's ataxia drug after hard-fought campaign

A drug approved for reimbursement by the HSE after a hard-fought campaign will bring life-changing benefits to hundreds of people in Ireland. Over 200 people across the country live with Friedreich's ataxia, a rare genetic disorder which causes damage to the spinal cord, cerebellum, and peripheral nerves and can lead to heart problems. It worsens […]